沃森生物(300142.SZ)：公司九价HPV疫苗目前处于III期临床研究阶段

Group 1 - The core point of the article is that Watson Bio (300142.SZ) is currently in the III phase of clinical research for its nine-valent HPV vaccine [1] Group 2 - The company is actively engaging with investors through an interactive platform to provide updates on its clinical research progress [1]